Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2096770
18404429
9047
10.1007/s11302-006-9047-6
Original Paper


P2 receptors in atherosclerosis and postangioplasty restenosis

Seye
Cheikh I.

+1-573-8841331
+1-573-8842537
seyec@missouri.edu

1

Kong
Qiongman

1

Yu
Ningpu

1

Gonzalez
Fernando A.

2

Erb
Laurie

1

Weisman
Gary A.

1

1
Department of Biochemistry, University of Missouri-Columbia, 540C Life Sciences Center, 1201 Rollins Road, Columbia, MO 65211-7310 USA 
2
Department of Chemistry, Rio Piedras Campus, University of Puerto Rico, San Juan, Puerto Rico 00931 

28
2
2007

3
2007

3
1-2
153
162
20
2
2006

20
4
2006


© Springer Science + Business Media B.V. 2007

2
 receptors in rabbit arteries mediates intimal hyperplasia [Seye et al. (Circulation 106:2720–726, 2002)]. In addition, upregulation of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model [Carpenter et al. (Stroke 32:516–22, 2001)] and in coronary artery of diabetic dyslipidemic pigs [Hill et al. (J Vasc Res 38:432–43, 2001)]. It has been proposed that upregulation of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis [Elmaleh et al. (Proc Natl Acad Sci U S A 95:691–95, 1998)]. Therefore, particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels, which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty.

Keywords
Atherosclerosis
Inflammation
Migration
Nucleotide receptors
Proliferation
Restenosis
Smooth muscle cell

issue-copyright-statement
© Springer Science + Business Media B.V. 2007




Introduction
1
10
4
11
5
]. A better understanding of the causative agents and mechanisms of proliferation and migration of vascular SMC as well as recruitment of blood-derived cells by the endothelium could lead to prevention, attenuation, or even reversal of intimal thickening, which may dramatically reduce morbidity and mortality from vascular diseases such as atherosclerosis and restenosis after angioplasty. In this respect, a better understanding of the physiological role of P2 receptors in both normal and pathological blood vessels could potentially lead to a breakthrough in the fight against vascular disease.

P2 receptors in the cardiovascular system
12
q/11
i/o
12
14
3
2+
1
2,
3,
4,
5,
6
7
1
2,
4,
6,
11,
12,
13,
14
) receptor subtypes has made it possible to use molecular and pharmacological approaches to study the distribution and functional properties of specific P2 receptor subtypes at the tissue and cellular level.

P2 receptors in vascular cells
2
2
1
2
4
6
4
2
1
2
15
2
16
17
1
2+
4
1
2
18
2
2
6
19
2
2
20
21
2
22
6
23
24
25
26
1
6
27
6
4
6
21
28
29
1
+
18
1
2
4
7
30
31
1
2
4
6
3
4
7
32
], further investigation is needed to establish the role of fibroblast P2 receptors in either physiological or pathophysiological conditions.

P2 receptors in blood cells
4
33
34
1
7
35
36
2
37
7
38
7
39
1,
4
7
7
40
1
2
6
41
1
12
1
42
44
]. Thus, the diversity of P2 receptor expression in blood cells, as well as endothelial cells, SMC, and fibroblasts, suggests that this receptor superfamily plays a significant role in the regulation of cardiovascular functions.

P2 receptors regulate nucleotide-induced vascular smooth muscle cell proliferation
45
46
47
48
49
50
51
2U
2
4
2
4
52
53
4
2
54
54
6
55
2
2
2
6
6
56
].

Role of P2 receptors in the migration of vascular SMC
57
2
57
2
28
58
4
1
58
1
1
58
6
2
4
58
].
51
6
57
57
59
57
osteopontin
60
osteopontin
61
osteopontin
 promoter (-1837 to -1757) that is responsive to UTP. This region contains an NFκB site located at -1800 and an Ebox located at -1768. Supershift electrophoretic mobility shift and chromatin immunoprecipitation assays identified NFκB and USF-1/USF-2 as DNA binding proteins induced by UTP. Using dominant negative mutants of IκB kinase and USF transcription factors, it was confirmed that NFκB and USF-1/USF-2 are involved in the UTP-induced expression of osteopontin.
62
] and the findings of previous studies demonstrating the mitogenic activity of extracellular nucleotides for these cells suggest that nucleotides released from mechanically stretched vascular or damaged cells during the angioplasty process may participate in arterial wall remodeling.

Role of P2 receptors in nucleotide-induced vascular inflammation
63
51
57
21
4
7
64
] for review), mediators of immune cell activation that is an early step in atherosclerotic lesion development.
65
66
67
69
63
70
].
2
6
2
71
], leading to their penetration into the vessel wall to promote arterial inflammation associated with atherosclerosis.
2
2
72
73
2
 receptors represent a novel target for reducing arterial inflammation associated with cardiovascular disease.

P2 receptors in vascular apoptosis
74
75
11
76
78
79
76
80
] and probably takes part in the normal process involved in the control of hyperplasia. In contrast, apoptosis of SMC in advanced human atherosclerotic plaques may destabilize the fibrous lesion to promote plaque rupture and its clinical consequences.
81
7
82
7
83
85
7
86
87
88
2b
89
].
7
90
7
83
91
96
7
97
7
98
7
74
7
99
]. These studies have provided compelling evidence suggesting a role for P2 and P1 receptor-mediated apoptosis in vascular diseases; however, further studies are needed to determine the precise pathways involved and to accumulate direct evidence that these pathways contribute significantly to the development of atherosclerosis, hypertension, and restenosis.

Modulation of P2 receptors in vascular injury
100
2
2
20
2
 mRNA was detected in all medial SMC of rat fetal aortas and in most of the aortic SMC of intimal lesions after balloon angioplasty, with an overexpression in cells lining the lumen both 1 and 3 weeks after injury.
100
2
6
2
2
2
4
6
2
54
2
6
4
 receptor mRNA was undetectable.
7
8
9
2
6
101
1
4
102
2
) are implicated in the development of vascular disease.

Pathophysiological significance of P2 receptor modulation in vascular injury
1
103
104
105
106
107
2
20
1
2
1
4
6
58
28
2
2
21
49
50
51
17
108
109
1
5
107
110
111
112
113
114
], are not regenerated.
2
21
29
115
2
116
21
50
117
118
119
] associated with the angioplasty process.
2
17
108
109
113
114
120
121
122
2
5
110
].

Conclusion
2
1
4
2
2
 receptor antagonists yet available, recent progress in siRNA technology has made it possible to design small RNA interference molecules that can selectively inhibit P2 receptor subtype expression. Such molecules can be efficiently delivered into the vessel wall using adenoviral vectors. In addition, P2 receptor transgenic mice (i.e., mice in which the relevant receptor subtype has been deleted or overexpressed) will be valuable tools to substantiate the role that nucleotides and P2 receptors play in the etiology of cardiovascular disease. Further delineation of the signaling pathways involved in these P2 receptor-mediated processes may help limit or prevent vascular diseases such as atherosclerosis and restenosis after angioplasty.


References
1.
Ross
R


The pathogenesis of atherosclerosis: a perspective for the 1990s
Nature
1993
362
6423
801
809
10.1038/362801a0

8479518


2.
Fuster
V

Badimon
L

Badimon
JJ

Chesebro
JH


The pathogenesis of coronary artery disease and the acute coronary syndromes (1)
N Engl J Med
1992
326
4
242
250

1727977


3.
Davies
MJ

Woolf
N


Atherosclerosis: what is it and why does it occur?
Br Heart J
1993
69
1
S3
S11
10.1136/hrt.69.1_Suppl.S3

8427761


4.
Virgilio
F

Solini
A


P2 receptors: new potential players in atherosclerosis
Br J Pharmacol
2002
135
4
831
842
10.1038/sj.bjp.0704524

11861311


5.
Lafont
A

Guzman
LA

Whitlow
PL

Goormastic
M

Cornhill
JF

Chisolm
GM


Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling
Circ Res
1995
76
6
996
1002

7758171


6.
Seye
CI

Kong
Q

Erb
L

Garrad
RC

Krugh
B

Wang
M

Turner
JT

Sturek
M

Gonzalez
FA

Weisman
GA


2
 nucleotide receptors mediate uridine 5–triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries
Circulation
2002
106
21
2720
2726
10.1161/01.CIR.0000038111.00518.35

12438299


7.
Carpenter
RC

Miao
L

Miyagi
Y

Bengten
E

Zhang
JH


2
 receptor mRNAs in the basilar artery in a rat double hemorrhage model
Stroke
2001
32
2
516
522

11157191


8.
Hill
BJ

Wamhoff
BR

Sturek
M


Functional nucleotide receptor expression and sarcoplasmic reticulum morphology in dedifferentiated porcine coronary smooth muscle cells
J Vasc Res
2001
38
5
432
443
10.1159/000051076

11561145


9.
Elmaleh
DR

Narula
J

Babich
JW

Petrov
A

Fischman
AJ

Khaw
BA

Rapaport
E

Zamecnik
PC


Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates
Proc Natl Acad Sci U S A
1998
95
2
691
695
10.1073/pnas.95.2.691

9435254


10.
Casscells
W


Migration of smooth muscle and endothelial cells. Critical events in restenosis
Circulation
1992
86
3
723
729

1516183


11.
Isner
JM

Kearney
M

Bortman
S

Passeri
J


Apoptosis in human atherosclerosis and restenosis
Circulation
1995
91
11
2703
2711

7758173


12.
North
RA

Surprenant
A


Pharmacology of cloned P2X receptors
Ann Rev Pharmacol Toxicol
2000
40
563
580
10.1146/annurev.pharmtox.40.1.563

10836147


13.
Cooper
DM

Rodbell
M


ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
Nature
1979
282
5738
517
518
10.1038/282517a0

503232


14.
Communi
D

Gonzales
NS

Detheux
M

Brezillon
S

Lannoy
V

Parmentier
M

Boeynaems
J-M


Identification of a novel human ADP receptor coupled to G1
J Biol Chem
2001
276
44
41479
41485
10.1074/jbc.M105912200

11546776


15.
Ralevic
V

Burnstock
G


Roles of P2-receptors in the cardiovascular system
Circulation
1991
84
1
1
14

1647896


16.
Saiag
B

Milon
D

Shacoori
V

Allain
H

Rault
B

Driessche
J


Newly evidenced pyrimidinoceptors and the P2X receptors are present on the vascular smooth muscle and respectively mediate the UTP- and ATP-induced contractions of the dog maxillary internal vein
Res Commun Chem Pathol Pharmacol
1992
76
1
89
94

1518963


17.
Kügelgen
I

Starke
K


Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2X-receptor, in rabbit basilar artery: A receptor for pyrimidine nucleotides and a receptor for purine nucleotides
Naunyn Schmiedebergs Arch Pharmacol
1990
341
6
538
546
10.1007/BF00171734

2118236


18.
Ralevic
V

Burnstock
G


Receptors for purines and pyrimidine
Pharmacol Rev
1998
50
3
413
492

9755289


19.
Guns
PJ

Assche
T

Fransen
P

Robaye
B

Boeynaems
JM

Bult
H


2
-deficient mice
Br J Pharmacol
2006
147
5
569
574
10.1038/sj.bjp.0706642

16415908


20.
Seye
CI

Gadeau
AP

Daret
D

Dupuch
F

Alzieu
P

Capron
L

Desgranges
C


2
 receptor in intimal lesions of the rat aorta
Arterioscler Thromb Vasc Biol
1997
17
12
3602
3610

9437211


21.
Malam-Souley
R

Seye
CI

Gadeau
AP

Loirand
G

Pillois
X

Campan
M

Pacaud
P

Desgranges
C


Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells
J Cell Physiol
1996
166
1
57
65
10.1002/(SICI)1097-4652(199601)166:1<57::AID-JCP7>3.0.CO;2-F

8557776


22.
Kumari
R

Goh
G

Ng
LL

Boarder
MR


2
 receptors
Br J Pharmacol
2003
140
7
1169
1176
10.1038/sj.bjp.0705526

14597595


23.
Malmsjo
M

Hou
M

Pendergast
W

Erlinge
D

Edvinsson
L


The stable pyrimidines UDPβS and UTPγS discriminate between contractile cerebrovascular P2 receptors
Eur J Pharmacol
2003
458
3
305
311
10.1016/S0014-2999(02)02787-5

12504787


24.
Malmsjo
M

Hou
M

Pendergast
W

Erlinge
D

Edvinsson
L


6
 receptor mediated contractions in human cerebral arteries
BMC Pharmacol
2003
3
4
10.1186/1471-2210-3-4

12737633


25.
Hartley
SA

Kato
K

Salter
KJ

Kozlowski
RZ


Functional evidence for a novel suramin-insensitive pyrimidine receptor in rat small pulmonary arteries
Circ Res
1998
83
9
940
946

9797343


26.
Malmsjo
M

Adner
M

Harden
TK

Pendergast
W

Edvinsson
L

Erlinge
D


The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery
Br J Pharmacol
2000
131
1
51
56
10.1038/sj.bjp.0703536

10960068


27.
Vial
C

Evans
RJ


1
6
-like receptor in arteries
Mol Pharmacol
2002
62
6
1438
1445
10.1124/mol.62.6.1438

12435812


28.
Erlinge
D

Hou
M

Webb
TE

Barnard
EA

Moller
S


Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR
Biochem Biophys Res Commun
1998
248
3
864
870
10.1006/bbrc.1998.9083

9704019


29.
Chang
K

Hanaoka
K

Kumada
M

Takuwa
Y


Molecular cloning and functional analysis of a novel P2 nucleotide receptor
J Biol Chem
1995
270
44
26152
26158
10.1074/jbc.270.44.26152

7592819


30.
Cario-Toumaniantz
C

Loirand
G

Ladoux
A

Pacaud
P


7
 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle
Circ Res
1998
83
2
196
203

9686759


31.
Zalewski
A

Shi
Y

Johnson
AG


Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?
Circ Res
2002
91
8
652
655
10.1161/01.RES.0000038996.97287.9A

12386139


32.
Kugelgen
I

Wetter
A


Molecular pharmacology of P2Y receptors
Naunyn Schmiedebergs Arch Pharmacol
2000
362
4–
310
323

11111826


33.
Kuhns
DB

Wright
DG

Nath
J

Kaplan
SS

Basford
RE


2+
i
2
−
 generation
Lab Invest
1988
58
4
448
453

2833660


34.
Cowen
DS

Lazarus
HM

Shurin
SB

Stoll
SE

Dubyak
GR


Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells
J Clin Invest
1989
83
5
1651
1660
10.1172/JCI114064

2708526


35.
Parker
JC

Snow
RL


Influence of external ATP on permeability and metabolism of dog red blood cells
Am J Physiol
1972
223
4
888
893

4627579


36.
Boyer
JL

Downes
CP

Harden
TK


Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides
J Biol Chem
1972
264
2
884
890

2910869


37.
Cockcroft
S

Stutchfield
J


ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C
FEBS Lett
1989
245
1–
25
29
10.1016/0014-5793(89)80184-X

2494077


38.
Steinberg
TH

Newman
AS

Swanson
JA

Silverstein
SC


4-
 permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes
J Biol Chem
1987
262
18
8884
8888

3597398


39.
Baricordi
OR

Ferrari
D

Melchiorri
L

Chiozzi
P

Hanau
S

Chiari
E

Rubini
M

Virgilio
F


An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes
Blood
1996
87
2
682
690

8555491


40.
Suh
BC

Kim
JS

Namgung
U

Ha
H

Kim
KT


7
 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils
J Immunol
2001
166
11
6754
6763

11359833


41.
Virgilio
F

Chiozzi
P

Ferrari
D

Falzoni
S

Sanz
JM

Morelli
A

Torboli
M

Bolognesi
G

Baricordi
OR


Nucleotide receptors: an emerging family of regulatory molecules in blood cells
Blood
2001
97
3
587
600
10.1182/blood.V97.3.587

11157473


42.
Sun
B

Li
J

Okahara
K

Kambayashi
J


1
 receptor in human platelets
J Biol Chem
1998
273
19
11544
11547
10.1074/jbc.273.19.11544

9565569


43.
Leon
C

Hechler
B

Vial
C

Leray
C

Cazenave
JP

Gachet
C


1
 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells
FEBS Lett
1997
403
1
26
30
10.1016/S0014-5793(97)00022-7

9038354


44.
Hollopeter
G

Jantzen
H-M

Vincent
D

Li
G

England
L

Ramakrishnan
V

Yang
R-B

Nurden
P

Nurden
A

Julius
D

Conley
PB


Identification of the platelet ADP receptor targeted by antithrombotic drugs
Nature
2001
409
6817
202
207
10.1038/35051599

11196645


45.
Hamada
K

Takuwa
N

Yokoyama
K

Takuwa
Y


Stretch activates Jun N-terminal kinase/stress-activated protein kinase in vascular smooth muscle cells through mechanisms involving autocrine ATP stimulation of receptors
J Biol Chem
1998
273
11
6334
6340
10.1074/jbc.273.11.6334

9497362


46.
Dubyak
GR

El-Moatassim
C


Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
Am J Physiol
1993
265
3 Pt 1
C577
C606

8214015


47.
Wang
DJ

Huang
NN

Heppel
LA


Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells
J Cell Physiol
1992
153
2
221
233
10.1002/jcp.1041530202

1358898


48.
White
PJ

Kumari
R

Porter
KE

London
NJ

Ng
LL

Boarder
MR


Antiproliferative effect of UTP on human arterial and venous smooth muscle cells
Am J Physiol Heart Circ Physiol
2000
279
6
H2735
H2742

11087228


49.
Erlinge
D

Yoo
H

Edvinsson
L

Reis
DJ

Wahlestedt
C


Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters
Am J Physiol
1993
265
4 Pt 2
H1089
H1097

7694483


50.
Erlinge
D

You
J

Wahlestedt
C

Edvinsson
L


Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells
Eur J Pharmacol
1995
289
135
149
10.1016/0922-4106(95)90178-7

7781705


51.
Malam-Souley
R

Campan
M

Gadeau
AP

Desgranges
C


Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells
Am J Physiol
1993
264
4 Pt 1
C783
C788

8097372


52.
Wildman
SS

Unwin
RJ

King
BF


2
4
+
2+
 ions. r
Br J Pharmacol
2003
140
7
1177
1186
10.1038/sj.bjp.0705544

14581177


53.
Harper
S

Webb
TE

Charlton
SJ

Ng
LL

Boarder
MR


4
 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP
Br J Pharmacol
1998
124
4
703
710
10.1038/sj.bjp.0701895

9690862


54.
Shen
J

Seye
CI

Wang
M

Weisman
GA

Wilden
PA

Sturek
M


2
 receptor in coronary artery smooth muscle cells
Mol Pharmacol
2004
66
5
1265
1274
10.1124/mol.104.002642

15280443


55.
Gadeau
AP

Campan
M

Millet
D

Candresse
T

Desgranges
C


Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro
Arterioscler Thromb
1993
13
1
120
125

8422334


56.
Hou
M

Harden
TK

Kuhn
CM

Baldetorp
B

Lazarowski
E

Pendergast
W

Moller
S

Edvinsson
L

Erlinge
D


6
 receptors
Am J Physiol Heart Circ Physiol
2002
282
2
H784
H792

11788430


57.
Chaulet
H

Desgranges
C

Renault
MA

Dupuch
F

Ezan
G

Peiretti
F

Loirand
G

Pacaud
P

Gadeau
AP


Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin
Circ Res
2001
89
9
772
778
10.1161/hh2101.098617

11679406


58.
Pillois
X

Chaulet
H

Belloc
I

Dupuch
F

Desgranges
C

Gadeau
AP


Nucleotide receptors involved in UTP–induced rat arterial smooth muscle cell migration
Circ Res
2002
90
6
678
681
10.1161/01.RES.0000013700.98464.8E

11934835


59.
Dufourcq
P

Louis
H

Moreau
C

Daret
D

Boisseau
MR

Lamaziere
JM

Bonnet
J


Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque
Arterioscler Thromb Vasc Biol
1998
18
2
168
176

9484980


60.
Renault
MA

Jalvy
S

Belloc
I

Pasquet
S

Sena
S

Olive
M

Desgranges
C

Gadeau
AP


AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells
Circ Res
2003
93
7
674
681
10.1161/01.RES.0000094747.05021.62

12970113


61.
Renault
MA

Jalvy
S

Potier
M

Belloc
I

Genot
E

Dekker
LV

Desgranges
C

Gadeau
AP


UTP induces osteopontin expression through a coordinate action of NFκB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells
J Biol Chem
2005
280
4
2708
2713
10.1074/jbc.M411786200

15557322


62.
Communi
D

Janssens
R

Suarez-Huerta
N

Robaye
B

Boeynaems
JM


Advances in signalling by extracellular nucleotides. The role and transduction mechanisms of P2Y receptors
Cell Signal
2000
12
6
351
360
10.1016/S0898-6568(00)00083-8

10889463


63.
Parker
AL

Likar
LL

Dawicki
DD

Rounds
S


Mechanism of ATP-induced leukocyte adherence to cultured pulmonary artery endothelial cells
Am J Physiol
1996
270
L695
L703

8967502


64.
Weisman
GA

Yu
N

Liao
Z

Gonzalez
F

Erb
L

Seye
CI


P2 receptors in health and disease
Biotechnol Genet
2005
22
171
195

Weisman GA, Yu N, Liao Z, Gonzalez F, Erb L, Seye CI (2005) P2 receptors in health and disease. Biotechnol Genet 22:171–95 

65.
Faruqi
RM

DiCorleto
PE


Mechanisms of monocyte recruitment and accumulation
Br Heart J
1993
69
S19
S29
10.1136/hrt.69.1_Suppl.S19

8427760


66.
Cybulsky
MI

Iiyama
K

Li
H

Zhu
S

Chen
M

Iiyama
M

Davis
V

Gutierrez-Ramos
JC

Connelly
PW

Milstone
DS


A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
J Clin Invest
2001
107
10
1255
1262
10.1172/JCI11871

11375415


67.
Rice
GE

Munro
JM

Bevilacqua
MP


Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism
J Exp Med
1990
171
4
1369
1374
10.1084/jem.171.4.1369

1691264


68.
Iademarco
MF

Barks
JL

Dean
DC


Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells
J Clin Invest
1995
95
1
264
271
10.1172/JCI117650

7529260


69.
Braun
M

Pietsch
P

Felix
SB

Baumann
G


Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines
J Mol Cell Cardiol
1995
27
12
2571
2579
10.1006/jmcc.1995.0044

8825878


70.
Ventura
MA

Thomopoulos
P


ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3
Mol Pharmacol
1995
47
1
104
107

7838119


71.
Seye
CI

Yu
N

Jain
R

Kong
Q

Minor
T

Newton
J

Erb
L

Gonzalez
FA

Weisman
GA


2
 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells
J Biol Chem
2003
278
27
24960
24965
10.1074/jbc.M301439200

12714597


72.
Liu
J

Liao
Z

Camden
J

Griffin
KD

Garrad
RC

Santiago-Perez
LI

Gonzalez
FA

Seye
CI

Weisman
GA

Erb
L


2
 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors
J Biol Chem
2004
279
9
8212
8218
10.1074/jbc.M312230200

14670955


73.
Seye
CI

Yu
N

Gonzalez
FA

Erb
L

Weisman
GA


2
 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1)
J Biol Chem
2004
279
34
35679
35686
10.1074/jbc.M401799200

15175347


74.
Mallat
Z

Tedgui
A


Apoptosis in the vasculature: mechanisms and functional importance
Br J Pharmacol
2000
130
5
947
962
10.1038/sj.bjp.0703407

10882378


75.
Thomas
WA

Reiner
JM

Florentin
FA

Lee
KT

Lee
WM


Population dynamics of arterial smooth muscle cells, V: cell proliferation and cell death during initial 3 months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimal trauma
Exp Mol Pathol
1976
24
3
360
374
10.1016/0014-4800(76)90071-X

1278334


76.
Han
DK

Haudenschild
CC

Hong
MK

Tinkle
BT

Leon
MB

Liau
G


Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
Am J Pathol
1995
147
2
267
277

7639326


77.
Geng
YJ

Libby
P


Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme
Am J Pathol
1995
147
2
251
266

7639325


78.
Crisby
M

Kallin
B

Thyberg
J

Zhivotovsky
B

Orrenius
S

Kostulas
V

Nilsson
J


Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
Atherosclerosis
1997
130
1–
17
27
10.1016/S0021-9150(96)06037-6

9126644


79.
Björkerud
S

Björkerud
B


Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
Am J Pathol
1996
149
2
367
380

8701977


80.
Bochaton-Piallat
ML

Gabbiani
F

Redard
M

Desmoulière
A

Gabbiani
G


Apoptosis participates in cellularity regulation during rat aortic intimal thickening
Am J Pathol
1995
146
5
1059
1064

7747800


81.
Burnstock
G


Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction
J Anat
1999
194
335
342
10.1046/j.1469-7580.1999.19430335.x

10386771


82.
Kaiser
D

Freyberg
MA

Friedl
P


Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells
Biochem Biophys Res Commun
1997
231
3
586
590
10.1006/bbrc.1997.6146

9070851


83.
Zheng
LM

Zychlinsky
A

Liu
CC

Ojcius
DM

Young
JD


Extracellular ATP as a trigger for apoptosis or programmed cell death
J Cell Biol
1991
112
2
279
288
10.1083/jcb.112.2.279

1988462


84.
Virgilio
F

Zanovello
P

Zambon
A

Bronte
V

Pizzo
P

Murgia
M


Cell membrane receptors for extracellular ATP: a new family of apoptosis-signalling molecules
Fundam Clin Immunol
1995
3
80
81

Di Virgilio F, Zanovello P, Zambon A, Bronte V, Pizzo P, Murgia M (1995) Cell membrane receptors for extracellular ATP: a new family of apoptosis-signalling molecules. Fundam Clin Immunol 3:80–1 

85.
Jacobson
KA

Hoffmann
C

Cattabeni
F

Abbracchio
MP


Adenosine-induced cell death: evidence for receptor-mediated signalling
Apoptosis
1999
4
3
197
211
10.1023/A:1009666707307

14634282


86.
Wen
LT

Caldwell
CC

Knowles
AF


7
 cells
Mol Pharmacol
2003
63
3
706
713
10.1124/mol.63.3.706

12606781


87.
Wang
Q

Wang
L

Feng
YH

Li
X

Zeng
R

Gorodeski
GI


7
 receptor-mediated apoptosis of human cervical epithelial cells
Am J Physiol Cell Physiol
2004
287
5
C1349
C1358
10.1152/ajpcell.00256.2004

15269006


88.
Kong
Q

Wang
M

Liao
Z

Camden
JM

Yu
S

Simonyi
A

Sun
GY

Gonzalez
FA

Erb
L

Seye
CI

Weisman
GA


7
 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons
Purinergic Signalling
2005
1
4
337
347
10.1007/s11302-005-7145-5

18404518


89.
Peyot
M

Gadeau
A

Dandré
F

Belloc
I

Dupuch
F

Desgranges
C


2b
-receptor
Circ Res
2000
86
1
76
85

10625308


90.
Solini
A

Chiozzi
P

Falzoni
S

Morelli
A

Fellin
R

Virgilio
F


7
 receptor-mediated function in human primary fibroblasts
Diabetologia
2000
43
10
1248
1256
10.1007/s001250051520

11079743


91.
Zanovello
P

Bronte
V

Rosato
A

Pizzo
P

Virgilio
F


Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation
J Immunol
1990
145
5
1545
1550

2384670


92.
Hogquist
KA

Nett
MA

Unanue
ER

Chaplin
DD


Interleukin 1 is processed and released during apoptosis
Proc Natl Acad Sci U S A
1991
88
19
8485
8491
10.1073/pnas.88.19.8485

1924307


93.
Lammas
DA

Stober
C

Harvey
CJ

Kendrick
N

Panchalingam
S

Kumararatne
DS


7
) receptors
Immunity
1997
7
3
433
444
10.1016/S1074-7613(00)80364-7

9324363


94.
Schulze-Lohoff
E

Hugo
C

Rost
S

Arnold
S

Gruber
A

Brune
B

Sterzel
RB


7
 receptors
Am J Physiol
1998
275
F962
F971

9843914


95.
Coutinho-Silva
R

Persechini
PM

Cunha Bisaggio
R

Perfettini
J

Torres de Santo
AC

Kanellopoulos
JM

Mottaly
I

Dautry-Varsat
A

Ojcius
DM


7
 receptor-dependent apoptosis of dendritic cells
Am J Physiol
1999
276
C1139
C1147

10329963


96.
Ferrari
D

Los
M

Bauer
MK

Vandenabeele
P

Wesselborg
S

Schulze-Osthoff
K


P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death
FEBS Lett
1999
447
1
71
75
10.1016/S0014-5793(99)00270-7

10218585


97.
Ferrari
D

Wesselborg
S

Bauer
MK

Schulze-Osthoff
K


Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65
J Cell Biol
1997
139
7
1635
1643
10.1083/jcb.139.7.1635

9412459


98.
Hu
Y

Fisette
PL

Denlinger
LC

Guadarrama
AG

Sommer
JA

Proctor
RA

Bertics
PJ


Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages
J Biol Chem
1998
273
42
27170
27175
10.1074/jbc.273.42.27170

9765236


99.
Albertini
M

Palmetshofer
A

Kaczmarek
E

Koziak
K

Stroka
D

Grey
ST

Stuhlmeier
KM

Robson
SC


Extracellular ATP and ADP activate transcription factor NF-κB and induce endothelial cell apoptosis
Biochem Biophys Res Commun
1998
248
3
822
829
10.1006/bbrc.1998.9055

9704012


100.
Meyer
GR

Put
DJ

Kockx
MM

Schil
P

Bosmans
R

Bult
H

Buyssens
N

Vanmaele
R

Herman
AG


Possible mechanisms of collar-induced intimal thickening
Arterioscler Thromb Vasc Biol
1997
17
10
1924
1930

9351355


101.
Wang
L

Andersson
M

Karlsson
L

Watson
MA

Cousens
DJ

Jern
S

Erlinge
D


Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium
Arterioscler Thromb Vasc Biol
2003
23
8
1370
1376
10.1161/01.ATV.0000080350.37408.5A

12791671


102.
Pulvirenti
TJ

Yin
JL

Chaufour
X

McLachlan
C

Hambly
BD

Bennett
MR

Barden
JA


P2X (purinergic) receptor redistribution in rabbit aorta following injury to endothelial cells and cholesterol feeding
J Neurocytol
2000
29
9
623
631
10.1023/A:1010828302936

11353286


103.
Katoh
Y

Periasamy
M


Growth and differentiation of smooth muscle cells during vascular development
Trends Cardiovasc Med
1996
6
100
106
10.1016/1050-1738(96)00014-X

Katoh Y, Periasamy M (1996) Growth and differentiation of smooth muscle cells during vascular development. Trends Cardiovasc Med 6:100–06 

104.
Owens
GK


Regulation of differentiation of vascular smooth muscle cells
Physiol Rev
1995
75
3
487
517

7624392


105.
Gabbiani
G

Kocher
O

Bloom
WS

Vandekerckhove
J

Weber
K


Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media
J Clin Invest
1984
73
1
148
152
10.1172/JCI111185

6690475


106.
Kocher
O

Gabbiani
F

Gabbiani
G

Reidy
MA

Cokay
M

Petters
H

Huttner
I


Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening: biochemical and morphologic studies
Lab Invest
1991
65
4
459
470

1921335


107.
Schwartz
SM

deBlois
D

O’Brien
ER


The intima: soil for atherosclerosis and restenosis
Circ Res
1995
77
3
445
465

7641318


108.
Ralevic
V

Burnstock
G


Effects of purines and pyrimidines on the rat mesenteric arterial bed
Circ Res
1991
69
6
1583
1590

1659504


109.
Saïag
B

Milon
D

Allain
H

Rault
B

Driessche
J


Constriction of the smooth muscle of rat tail and femoral arteries and dog saphenous vein is induced by uridine triphosphate via ‘pyrimidinoceptors– and by adenosine triphosphate via P2X receptors
Blood Vessels
1990
27
6
352
354

2178007


110.
Andersen
HR

Mæng
M

Thorwest
M

Falk
E


Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model
Circulation
1996
93
9
1716
1724

8653878


111.
Clowes
AW

Clowes
MM

Reidy
MA


Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels
Lab Invest
1986
54
3
295
303

3512908


112.
Haudenschild
CC

Schwartz
SM


Endothelial regeneration. II. Restitution of endothelial continuity
Lab Invest
1979
41
5
407
418

502473


113.
Shimokawa
H

Flavahan
NA

Vanhoutte
PM


Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries: possible dysfunction of a pertussis toxin-sensitive G protein
Circ Res
1989
65
3
740
753

2504508


114.
Weidinger
FF

McLenachan
JM

Cybulsky
MI

Gordon
JB

Rennke
HG

Hollenberg
NK

Fallon
JT

Ganz
P

Cooke
JP


Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery
Circulation
1990
81
5
1667
1679

2139594


115.
Valera
S

Hussy
N

Evans
RJ

Adami
N

North
RA

Surprenant
A

Buell
G


A new class of ligand gated ion channel defined by P2X receptor for extracellular ATP
Nature
1994
371
6497
516
519
10.1038/371516a0

7523951


116.
Nicholas
RA

Watt
WC

Lazarowski
ER

Li
Q

Harden
TK


Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor
Mol Pharmacol
1996
50
2
224
229

8700127


117.
Gordon
JL


Extracellular ATP: effects, sources and fate
Biochem J
1986
233
2
309
319

3006665


118.
Bergfeld
GR

Forrester
T


Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia
Cardiovasc Res
1992
26
1
40
47
10.1093/cvr/26.1.40

1325292


119.
Bodin
P

Burnstock
G


Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells
Experientia
1995
51
3
256
259
10.1007/BF01931108

7698289


120.
Viswanathan
M

Strömberg
C

Seltzer
A

Saavedra
JM


Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta
J Clin Invest
1992
90
5
1707
1712
10.1172/JCI116043

1331171


121.
Winkles
JA

Alberts
GF

Brogi
E

Libby
P


Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries
Biochem Biophys Res Commun
1993
191
3
1081
1088
10.1006/bbrc.1993.1327

8466485


122.
Majesky
MW

Reidy
MA

Bowen-Pope
DF

Hart
CE

Wilcox
JN


PDGF ligand and receptor gene expression during repair of arterial injury
J Cell Biol
1990
111
2149
2158
10.1083/jcb.111.5.2149

2172262





